COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
Eckert & Ziegler SE implements share split, issuing bonus shares effective August 15, 2025, tripling tradable shares for improved liquidity without changing shareholder percentages -
-
-
COMMUNIQUÉ DE PRESSE
Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA -
-
-
COMMUNIQUÉ DE PRESSE
Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
Eckert & Ziegler SE increases capital and prepares for share split, aiming to enhance share liquidity and trading. Leading in isotope-related components for nuclear medicine and radiation therapy
